Otte Maximilian, Nestle-Krämling Carolin, Fertsch Sonia, Hagouan Mazen, Munder Beatrix, Richrath Philip, Stambera Peter, Abu-Ghazaleh Alina, Andree Christoph
1 Department of Plastic and Aesthetic Surgery, 2 Department of Senology, Sana Kliniken Düsseldorf, Düsseldorf, Germany.
Gland Surg. 2016 Feb;5(1):24-31. doi: 10.3978/j.issn.2227-684X.2015.05.15.
With the development of conservative mastectomies, there are an increasing number of women seeking immediate implant based and autologous breast reconstruction. Despite the oncologic safety of the procedures, the focus will be on the timing of reconstruction.
Our plastic surgery unit is focused primarily on autologous breast reconstruction and is part of an interdisciplinary breast center. We offer immediate breast reconstruction (IBR) with autologous tissue for patients with positive BRCA 1 and 2, ductal carcinoma in situ (DCIS), invasive cancer without margin problems to the skin, as well as to correct poor oncologic and aesthetic breast conserving therapy (BCT) outcomes. In the majority of cases we prefer an Immediate-DElayed AutoLogous (IDEAL) breast reconstruction concept with a two-stage procedure.
Over the last 10 years we performed more than 1,600 breast reconstructions with free flaps, performing the deep inferior epigastric perforator (DIEP) flap as our first choice for autologous tissue. We recommend IDEAL breast reconstruction, however approximately 15% of our cases are immediate one stage conservative mastectomies and breast reconstruction with the DIEP flap.
For immediate reconstruction, the aesthetic outcome should not take precedence over oncologic considerations. Immediate one-stage, breast reconstruction with autologous tissue can be offered to the suitable patients which is most likely a healthy women with a small-to-medium sized non ptotic breast receiving a conservative mastectomy. In all other cases, we recommend an IDEAL breast reconstruction approach in order to achieve a final result that is both satisfyingly pleasing and oncologically safe.
随着保乳手术的发展,越来越多的女性寻求即刻乳房植入和自体乳房重建。尽管这些手术在肿瘤学上是安全的,但重点将放在重建的时机上。
我们的整形外科主要专注于自体乳房重建,是一个跨学科乳腺中心的一部分。我们为携带BRCA 1和2基因、导管原位癌(DCIS)、无皮肤切缘问题的浸润性癌患者,以及为纠正肿瘤学和美学效果不佳的保乳治疗(BCT)结果,提供自体组织即刻乳房重建(IBR)。在大多数情况下,我们倾向于采用两阶段手术的即刻延迟自体(IDEAL)乳房重建概念。
在过去10年中,我们使用游离皮瓣进行了1600多例乳房重建手术,将腹壁下深动脉穿支(DIEP)皮瓣作为自体组织的首选。我们推荐IDEAL乳房重建,然而,我们约15%的病例是即刻一期保乳手术并使用DIEP皮瓣进行乳房重建。
对于即刻重建,美学效果不应优先于肿瘤学考虑因素。可以为合适的患者提供即刻一期自体组织乳房重建,这些患者很可能是健康的、乳房中小且不下垂并接受保乳手术的女性。在所有其他情况下,我们推荐采用IDEAL乳房重建方法,以获得既令人满意又在肿瘤学上安全的最终效果。